C.S. John Kim

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Suppression-Replacement KCNQ1 Gene Therapy for Type 1 Long QT Syndrome”.

Suppression-Replacement KCNQ1 Gene Therapy for Type 1 Long QT Syndrome

Circulation(2021)10.1161/circulationaha.120.051836

N/A

0DataRank · unranked

86 citations

C.S. John Kim, William A.C. Gendron, Wei Zhou, Dan Ye, J. Martijn Bos +4 more

Characterization of N-terminal RYR2 variants outside CPVT1 hotspot regions using patient iPSCs reveal pathogenesis and therapeutic potential

Stem Cell Reports(2022)10.1016/j.stemcr.2022.07.002

N/A

0DataRank · unranked

11 citations

C.S. John Kim, David J. Tester, Samantha K. Hamrick, Steven M. Dotzler, John R. Giudicessi +6 more

Cellular and electrophysiological characterization of triadin knockout syndrome using induced pluripotent stem cell-derived cardiomyocytes

Stem Cell Reports(2023)10.1016/j.stemcr.2023.04.005

N/A

0DataRank · unranked

12 citations

Dan Ye, Lili Wang, C.S. John Kim, Wei Zhou, Steven M. Dotzler +5 more